Skip to main content
Online First
FDA Updates
Jakafi a New Treatment Option for Chronic Graft-Versus-Host Disease
Read More
Online First
FDA Updates
Cabometyx Receives FDA Approval for Differentiated Thyroid Cancer
Read More
FDA Updates
Brukinsa Approved for Marginal-Zone Lymphoma and for Waldenström’s Macroglobulinemia
Read More
Online First
FDA Updates
Nivolumab First Immunotherapy Approved for Adjuvant Treatment of Urothelial Carcinoma
Read More
Online First
FDA Updates
Jemperli Another Therapy Approved for Patients with dMMR Recurrent or Advanced Solid Tumors
Read More
Online First
FDA Updates
Lenvima plus Keytruda a New Combination Approved for Advanced Renal-Cell Carcinoma
Read More
Meeting Highlights
Multiple Myeloma, ASCO Highlights
New CAR T-Cell Therapy Produces Durable Responses in Relapsed or Refractory Multiple Myeloma
Wayne Kuznar
Wayne Kuznar
Read More
IWTI Best Practices in GU Navigation
Interview with the Innovators
Quality of Life with Combination Therapy in Advanced Renal-Cell Cancer
Megan Price, MSN, APRN, FNP-C, Virginia Seery, MSN, RN, ANP-BC, AOCNP, Laura Wood, RN, MSN, OCN
Read More
FDA Updates
Pylarify Second Radioactive Imaging Drug FDA Approved for PSMA-Positive Prostate Cancer
Read More
Meeting Highlights
Biosimilars, ASCO Highlights
Rapid Biosimilar Adoption Possible in Community Oncology Practice
Chase Doyle
Chase Doyle
Read More
Page 86 of 199
Results 851 - 860 of 1986